Biotech
MONTREAL, CANADA: MONTREAL, CANADA -- (Marketwired) -- 08/07/13 -- Paladin Labs Inc. (TSX: PLB), a leading Canadian specialty pharmaceutical company, will release its second quarter 2013 financial results on Wednesda ...
EDMONTON, ALBERTA: EDMONTON, ALBERTA -- (Marketwired) -- 08/07/13 -- Ceapro Inc. (TSX VENTURE: CZO) is pleased to announce today that it has signed an Offer Letter with Agriculture Financial Services Corporation (AFSC ...
MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwired) -- 08/06/13 -- Thallion Pharmaceuticals Inc. ("Thallion") (TSX VENTURE: TLN) and BELLUS Health Inc. (TSX: BLU) ("BELLUS Health") announced today ...
SAN FRANCISCO, CA: SAN FRANCISCO, CA -- (Marketwired) -- 08/06/13 -- Medivation, Inc. (NASDAQ: MDVN) today announced that it will present at the following conference:David Hung, M.D., president and chief executive offi ...
SAN DIEGO, CA: SAN DIEGO, CA -- (Marketwired) -- 08/06/13 -- Adamis Pharmaceuticals Corporation (OTCQB: ADMP) announced today that it has entered into an agreement to exclusively license and, with additional paymen ...
NEW YORK, NY: NEW YORK, NY -- (Marketwired) -- 08/06/13 -- Crystal Research Associates, LLC announced today that it has issued an Executive Informational Overview® (EIO) on International Stem Cell Corporation (OT ...
CARY, NC: CARY, NC -- (Marketwired) -- 08/06/13 -- Cornerstone Therapeutics Inc. (NASDAQ: CRTX)Record net revenue for the second consecutive quarter, up 88% compared to the second quarter of 2012Earnings per s ...
SAN DIEGO, CA: SAN DIEGO, CA -- (Marketwired) -- 08/05/13 -- Vital Therapies®, Inc., a biopharmaceutical company focused on developing a cell-based therapy targeting the treatment of acute liver failure, today ann ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 08/02/13 -- enGene Inc., a pre-clinical stage biopharmaceutical company developing a platform technology for the robust delivery of nucleotides (DNA or RNA) to t ...
MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwired) -- 08/02/13 -- Thallion Pharmaceuticals Inc. ("Thallion") (TSX VENTURE: TLN) and BELLUS Health Inc. (TSX: BLU) ("BELLUS Health") announced today ...
HALIFAX, NOVA SCOTIA: Support from Province of Nova Scotia Offers Validation of IMV Clinical Programs; Ensures Funding Available for Additional Clinical Development in Coming Years ...
MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwired) -- 08/02/13 -- Thallion Pharmaceuticals Inc. ("Thallion") (TSX VENTURE: TLN) and BELLUS Health Inc. (TSX: BLU) ("BELLUS Health") announced today ...
MANCHESTER, NH: MANCHESTER, NH -- (Marketwired) -- 08/02/13 -- Boston Therapeutics, Inc. (OTCQB: BTHE) ("Boston Therapeutics" or "the Company"), a pharmaceutical company developing and commercial ...
CARLSBAD, CA: CARLSBAD, CA -- (Marketwired) -- 08/01/13 -- International Stem Cell Corporation (OTCQB: ISCO) () a California-based biotechnology company developing novel stem cell based therapies and biomedical pr ...
PALATINE, IL: PALATINE, IL -- (Marketwired) -- 08/01/13 -- Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company developing products intended to address medication abuse and misuse, announ ...
MENLO PARK, CA: MENLO PARK, CA -- (Marketwired) -- 08/01/13 -- Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report second quarter 2013 financial results on August 8, 2013. The Company wil ...
MELBOURNE, AUSTRALIA: MELBOURNE, AUSTRALIA -- (Marketwired) -- 08/01/13 -- Prana Biotechnology (NASDAQ: PRAN) (ASX: PBT) has today announced the first of several key appointments in the near term to advance PBT2 into late ...
EXTON, PA: EXTON, PA -- (Marketwired) -- 08/01/13 -- (NYSE: WST)Conference Call Scheduled for 9 a.m. TodayExton, PA -- August 1, 2013 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its finan ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 08/01/13 -- Threshold Pharmaceuticals, Inc. (NASDAQ: THLD), today reported financial results for the second quarter of 2013. Revenue for the second quarter ...
EXTON, PA: EXTON, PA -- (Marketwired) -- 08/01/13 -- West Pharmaceutical Services, Inc. (NYSE: WST) ("West") today announced that the Company's Board of Directors has approved a two-for-one split ...
